NASDAQ: RAPT
Rapt Therapeutics Inc Stock Ownership - Who owns Rapt Therapeutics?

Insider buying vs selling

Have Rapt Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RAPT insiders and whales buy or sell their stock.

RAPT Shareholders

What type of owners hold Rapt Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medicxi Ventures Management Jersey Ltd16.93%22,352,000$20.59MInstitution
Medicxi Ventures Management Jersey Ltd16.93%22,352,000$20.59MInsider
Orbimed Advisors LLC9.95%13,135,260$12.10MInstitution
Tcg Crossover Management LLC9.95%13,135,260$12.10MInstitution
Foresite Capital Management VI LLC9.47%12,500,000$11.51MInstitution
Rtw Investments LP8.91%11,764,000$10.83MInstitution
Bvf Inc7.00%9,237,556$8.51MInstitution
David V. Goeddel5.13%6,777,151$6.24MInsider
Redmile Group LLC4.91%6,475,317$5.96MInstitution
Deep Track Capital LP4.55%6,011,380$5.54MInstitution

1 of 3

RAPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RAPT76.59%23.41%
SCPH64.26%35.74%Net Buying
LXEO80.55%19.45%Net SellingNet Buying
CHRS56.32%18.16%Net Selling
ENTA58.38%41.62%Net SellingNet Buying

Rapt Therapeutics Stock Ownership FAQ

Who owns Rapt Therapeutics?

Rapt Therapeutics (NASDAQ: RAPT) is owned by 96.05% institutional shareholders, 29.35% Rapt Therapeutics insiders, and 0.00% retail investors. Medicxi Ventures Management Jersey Ltd is the largest individual Rapt Therapeutics shareholder, owning 22.35M shares representing 16.93% of the company. Medicxi Ventures Management Jersey Ltd's Rapt Therapeutics shares are currently valued at $20.25M.

If you're new to stock investing, here's how to buy Rapt Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.